Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 267

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 267
---
OFIFORM 20-F2024 |

| PART I                                                    |
| ITEM 7. Major Shareholders and Related Party Transactions |

As of December 31, 2024, Sanofi had approximately 27,247 shareholders listed in its share register, representing approximately 13.20% of issued shares. Based on the Sanofi share register and excluding treasury shares, approximately 98.40% of the shares registered by name were held in France, and approximately 0.011% were held in the United States. In France, our country of incorporation, there were 11,552 identified shareholders of record. In the United States, our host country, there were 53 identified shareholders of record and 17,526 i dentified ADS holders of record. Shareholders’ Agreement We are unaware of any shareholders’ agreement currently in force. B. Related Party Transactions See Note D.33. to our consolidated financial statements included at Item 18. of this annual report. On February 2, 2025, Sanofi and L'Oréal entered into a share buyback agreement pursuant to which Sanofi repurchased 29,556,650 shares from L’Oréal, a significant shareholder, at €101.50 per share, for a total amount of approximately €3 billion. After the transaction and cancellation of the shares, L’Oréal will hold 7.2% of Sanofi’s share capital and 13.1% of its actual voting rights (excluding treasury shares). The transaction closed on February 5, 2025. Sanofi will cancel the shares acquired from L'Oréal at the latest on April 29, 2025. For more information, see "Item 8. Financial Information - B. Significant Changes". C. Interests of Experts and Counsel N/A

| SANOFIFORM 20-F2024 | 161 |

| PART I                        |
| ITEM 8. Financial Information |

Item 8. Financial Information A. Consolidated Financial Statements and Other Financial Information Our consolidated financial statements as of and for the years ended December 31, 2024 , 2023 and 2022 are included in this annual report at “Item 18. Financial Statements.” Dividends on ordinary shares We paid annual dividends for the years ended December 31, 2020 , 2021 , 2022 and 2023 and our shareholders will be asked to approve the payment of an annual dividend of € 3.92 per share for the 2024